Home > News > Three Decades From Now
August 3rd, 2008
Three Decades From Now
It takes 20 years, give or take, for a new technology to move through multiple cycles of development, commercialization, and competition necessary to evolve from experimental prototype to widespread maturity. A look back at the past few decades of medical progress suggests that 30 years is more likely in that field - there's one effect of regulation for you, a slowing of the technologies that manage to make it over the regulatory hurdle in the first place.
What does this pace of progress in medicine mean for middle-aged and younger people today? It means that the 2030s will see widespread, cost-effective use of the medical technologies you presently read about in the science press. A small selection:
* Replacement organs will be grown to order from your own cells.
* Stem cells will be created, manipulated, and transplanted to direct extraordinary regeneration
* Age-damaged immune systems will be wiped clean and replaced afresh.
* Gene therapy will be a mature technology, and genetic disorders curable.
* Everyone will know their DNA sequence, and have access to a vast database of knowledge that describes risks, therapies, and best practices.
* Cancer will be detected early, and even late-stage metastasis cured with few side-effects by nanoparticle-based, viral, or other therapies.
* The important mitochondrial DNA will be replaced when damaged by disease or age.
* Many of the biochemical processes underlying the benefits of exercise, calorie restriction, and known human longevity-associated genes will be reproduced by cheap drugs.
News and information
Iranian Researchers Synthesize Stable Ceramic Nanopowders at Room Temperature September 20th, 2014
Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014
SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014
Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Produced Water Absorbents, Inc. July 9th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With HZO, Inc. June 12th, 2014
3D printing and microrobots making progress on building tissue with blood vessels which will enable large printed organs June 1st, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Nanosys, Inc. May 30th, 2014
Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013
utsandiego.com November 22nd, 2012
Nanoparticles against aging October 3rd, 2012
Frost & Sullivan Hosts Webinar: Can We Live Forever? Gauging the Future Trajectory of Medical Technology Development March 24th, 2011